Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis

PURPOSE: With increasing environmental pollution, the incidence of allergic conjunctivitis is increasing. Newer anti-allergic medications with combined anti-histaminic and mast cell stabilization action can help reducing the use of topical steroids for milder form of disease. There is no study direc...

Descripción completa

Detalles Bibliográficos
Autores principales: Dudeja, Lakshey, Janakiraman, Anuja, Dudeja, Ishani, Sane, Kaustubh, Babu, Manohar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727736/
https://www.ncbi.nlm.nih.gov/pubmed/31436181
http://dx.doi.org/10.4103/ijo.IJO_2112_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727736/
https://www.ncbi.nlm.nih.gov/pubmed/31436181
http://dx.doi.org/10.4103/ijo.IJO_2112_18

Ejemplares similares